Skip to main content
Log in

Impact of a clinical decision support system for drug dosage in patients with renal failure

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background A clinical decision support system (CDSS) linked to the computerized physician order entry may help improve prescription appropriateness in inpatients with renal insufficiency. Objective To evaluate the impact on prescription appropriateness of a CDSS prescriber alert for 85 drugs in renal failure patients. Setting Before-after study in a 975-bed academic hospital. Method Prescriptions of patients with renal failure were reviewed during two comparable periods of 6 days each, before and after the implementation of the CDSS (September 2009 and 2010). Main outcome measure The proportion of inappropriate dosages of 85 drugs included in the CDSS was compared in the pre- and post-implementation group. Results Six hundred and fifteen patients were included in the study (301 in pre- and 314 in post-implementation periods). In the pre- and post-implementation period, respectively 2882 and 3485 prescriptions were evaluated, of which 14.9 and 16.6% triggered an alert. Among these, the dosage was inappropriate in respectively 25.4 and 24.6% of prescriptions in the pre- and post-implementation periods (OR 0.97; 95% CI 0.72–1.29). The most frequently involved drugs were paracetamol, perindopril, tramadol and allopurinol. Conclusion The implementation of a CDSS did not significantly reduce the proportion of inappropriate drug dosages in patients with renal failure. Further research is required to investigate the reasons why prescribers override alerts. Collaboration with clinical pharmacists might improve compliance with the CDSS recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Munar MY, Singh H. Drug dosing adjustments in patients with chronic kidney disease. Am Fam Phys. 2007;75(10):1487–96.

    Google Scholar 

  2. Breton G, Froissart M, Janus N, Launay-Vacher V, Berr C, Tzourio C, et al. Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function—the Three-City population-based study. Nephrol Dial Transpl. 2011;26(9):2852–9.

    Article  Google Scholar 

  3. Blix HS, Viktil KK, Moger TA, Reikvam A. Use of renal risk drugs in hospitalized patients with impaired renal function—an underestimated problem? Nephrol Dial Transpl. 2006;21(11):3164–71.

    Article  Google Scholar 

  4. Roberts GW, Farmer CJ, Cheney PC, Govis SM, Belcher TW, Walsh SA, et al. Clinical decision support implemented with academic detailing improves prescribing of key renally cleared drugs in the hospital setting. J Am Med Inf Assoc (JAMIA). 2010;17(3):308–12.

    Article  Google Scholar 

  5. Hug BL, Witkowski DJ, Sox CM, Keohane CA, Seger DL, Yoon C, et al. Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney. Kidney Int. 2009;76(11):1192–8.

    Article  Google Scholar 

  6. Pillans PI, Landsberg PG, Fleming AM, Fanning M, Sturtevant JM. Evaluation of dosage adjustment in patients with renal impairment. Intern Med J. 2003;33(1–2):10–3.

    Article  CAS  Google Scholar 

  7. Salomon L, Levu S, Deray G, Launay-Vacher V, Brucker G, Ravaud P. Assessing residents’ prescribing behavior in renal impairment. Int J Qual Health Care. 2003;15(3):235–40.

    Article  CAS  Google Scholar 

  8. Salomon L, Deray G, Jaudon MC, Chebassier C, Bossi P, Launay-Vacher V, et al. Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care. 2003;15(4):331–5.

    Article  CAS  Google Scholar 

  9. van Dijk EA, Drabbe NR, Kruijtbosch M, De Smet PA. Drug dosage adjustments according to renal function at hospital discharge. Ann Pharmacother. 2006;40(7–8):1254–60.

    Article  Google Scholar 

  10. Chertow GM, Lee J, Kuperman GJ, Burdick E, Horsky J, Seger DL, et al. Guided medication dosing for inpatients with renal insufficiency. J Am Med Assoc (JAMA). 2001;86(22):2839–44.

    Article  Google Scholar 

  11. Aronoff GR, Aronoff JR. Drug prescribing in kidney disease: can’t we do better? Am J Kidney Dis. 2014;63(3):382–3.

    Article  Google Scholar 

  12. Stemer G, Lemmens-Gruber R. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC Nephrol. 2014;12:35.

    Article  Google Scholar 

  13. Cabello-Muriel A, Gascon-Canovas JJ, Urbieta-Sanz E, Iniesta-Navalon C. Effectiveness of pharmacist intervention in patients with chronic kidney disease. Int J Clin Pharm. 2014;36(5):896–903.

    Article  Google Scholar 

  14. Nuckols TKS-SC, Smith-Spangler C, Morton SC, Asch SM, Patel VM, Anderson LJ, et al. The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta-analysis. Syst Rev. 2014;4(3):56.

    Article  Google Scholar 

  15. Terrell KM, Perkins AJ, Hui SL, Callahan CM, Dexter PR, Miller DK. Computerized decision support for medication dosing in renal insufficiency: a randomized, controlled trial. Ann Emerg Med. 2010;56(6):623–9.

    Article  Google Scholar 

  16. Sellier E, Colombet I, Sabatier B, Breton G, Nies J, Zapletal E, et al. Effect of alerts for drug dosage adjustment in inpatients with renal insufficiency. J Am Med Inf Assoc (JAMIA). 2009;16(2):203–10. https://doi.org/10.1197/jamia.m2805.

    Article  Google Scholar 

  17. SPC. Summary of product characteristics. www.fagg-afmpsbe. Accessed 15 May 2017.

  18. Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA et al. Drug prescribing in renal failure, dosing guidelines for adults. American College of Physicians. 2007. ISBN: 978-1-930513-76-1.

  19. Lacy CF, Armstrong LL, Goldman MP, Lance LL. Drug information handbook. 2009–2010. ISBN 13: 978-1-591952-54-1.

  20. Pai MP. Estimating the glomerular filtration rate in obese adult patients for drug dosing. Adv Chronic Kidney Dis. 2010;17(5):e53–62.

    Article  Google Scholar 

  21. Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis. 2005;46(2):233–41.

    Article  CAS  Google Scholar 

  22. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the modification of diet in renal disease and cockcroft-gault equations for estimating renal function. J Am Soc Nephrol. 2005;16:763–73.

    Article  Google Scholar 

  23. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.

    Article  CAS  Google Scholar 

  24. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247–54.

    Article  CAS  Google Scholar 

  25. Helou R. Should we continue to use the Cockcroft–Gault formula? Nephron Clin Pract. 2010;116(3):c172–86.

    Article  Google Scholar 

  26. Stevens LA, Nolin TD, Richardson MM, Feldman HI, Lewis JB, Rodby R, et al. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis. 2009;54(1):33–42.

    Article  CAS  Google Scholar 

  27. Gill J, Malyuk R, Djurdjev O, Levin A. Use of GFR equations to adjust drug doses in an elderly multi-ethnic group—a cautionary tale. Nephrol Dial Transpl. 2007;22(10):2894–9.

    Article  Google Scholar 

  28. Van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inf Assoc (JAMIA). 2006;13:138–47.

    Article  Google Scholar 

  29. Scheepers-Hoeks AM, Grouls RJ, Neef C, Korsten HH. Strategy for implementation and first results of advanced clinical decision support in hospital pharmacy practice. Stud Health Technol Inf. 2009;148:142–8.

    CAS  Google Scholar 

  30. Judge J, Field TS, DeFlorio M, Laprino J, Auger J, Rochon P, et al. Prescribers’ responses to alerts during medication ordering in the long term care setting. J Am Med Inf Assoc (JAMIA). 2006;13(4):385–90.

    Article  Google Scholar 

  31. Czock D, Konias M, Seidling HM, Kaltschmidt J, Schwenger V, Zeier M, et al. Tailoring of alerts substantially reduces the alert burden in computerized clinical decision support for drugs that should be avoided in patients with renal disease. J Am Med Inf Assoc (JAMIA). 2015;22(4):881–7.

    Article  Google Scholar 

  32. Cho I, Slight SP, Nanji KC, Seger DL, Maniam N, Dykes PC, et al. Understanding physicians’ behavior toward alerts about nephrotoxic medications in outpatients: a cross-sectional analysis. BMC Nephrol. 2014;15:200.

    Article  Google Scholar 

  33. Brown C, Hofer T, Johal A, Thomson R, Nicholl J, Franklin B, et al. An epistemology of patient safety research: a framework for study design and interpretation. Part 2. Study design. Qual Saf Health Care. 2008;17:163–9.

    Article  CAS  Google Scholar 

  34. Bertrand J, Genevay S, Saudan P. Traitement de la goutte chez l’insuffisant rénal. Rev Med Suisse. 2011;7:483–9.

    CAS  PubMed  Google Scholar 

  35. Melton BL, Zillich AJ, Russell SA, Weiner M, McManus MS, Spina JR, et al. Reducing prescribing errors through creatinine clearance alert redesign. Am J Med. 2015;128(10):1117–25.

    Article  Google Scholar 

  36. Such Díaz A, Saez de la Fuente J, Esteva L, Alañón Pardo A, Barrueco N, Esteban C et al. Drug prescribing in patients with renal impairment optimized by a computer-based, semi-automated system. Int J Clin Pharm. 2013;35(6):1170–7.

    Article  Google Scholar 

  37. Cornu P, Steurbaut S, Sostaric S, Mrhar A, Dupont AG. Performance of a clinical decision support system and of clinical pharmacists in preventing drug-drug interactions on a geriatric ward. Int J Clin Pharm. 2014;36(3):519–25.

    Article  CAS  Google Scholar 

  38. Spinewine A, Dhillon S, Mallet L, Tulkens PM, Wilmotte L, Swine C. Implementation of ward-based clinical pharmacy services in Belgium—description of the impact on a geriatric unit. Ann Pharmacother. 2006;40(4):720–8.

    Article  Google Scholar 

  39. Falconnier AD, Haefeli WE, Schoenenberger RA, Surber C, Martin-Facklam M. Drug dosage in patients with renal failure optimized by immediate concurrent feedback. J Gen Intern Med. 2001;16(6):369–75.

    Article  CAS  Google Scholar 

  40. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72(3):247–59.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank M. Demey (IT department) for the development of the CDSS at the Cliniques universitaires Saint-Luc, Brussels, S. Thevelin and V. Mohymont.

Funding

No specific funding was received for this research.

Conflicts of interest

None. The authors have no conflicts of interest that are directly relevant to the content of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olivia Dalleur.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Desmedt, S., Spinewine, A., Jadoul, M. et al. Impact of a clinical decision support system for drug dosage in patients with renal failure. Int J Clin Pharm 40, 1225–1233 (2018). https://doi.org/10.1007/s11096-018-0612-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-018-0612-1

Keywords

Navigation